Form 483

Virginia Center for Reproductive Medicine Form 483, 2021-10-29

FDA issued a Form 483 to Virginia Center for Reproductive Medicine on 2021-10-29 with 9 public-safe observations.

483· Form 483 issuedBiologics9 observations

Virginia Center for Reproductive Medicine · Reston, United States · Issued October 29, 2021

Overview

  • 9 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Oct 2021
21 CFR 1271.50(b)(1)

Donor screening standards

Cited by Richard J Bashay, Kenneth L Smalls

29 Oct 2021
21 CFR 1271.50(b)(1)

Donor screening standards

Cited by Richard J Bashay, Kenneth L Smalls

29 Oct 2021
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Richard J Bashay, Kenneth L Smalls

29 Oct 2021
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Richard J Bashay, Kenneth L Smalls

29 Oct 2021
21 CFR 1271.90(c)

Eligibility not required--warning labels

Cited by Richard J Bashay, Kenneth L Smalls

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.50(b)(1)Cited across public-safe Form 483 observations3x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations3x
21 CFR 1271.90(c)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere